267
roles and current perspectives. Exp Mol Pathol
96:98–107. https://doi.org/10.1016/j.
yexmp.2013.12.004
- Maroof H, Salajegheh A, Smith RA, Lam AK
(2014) Role of microRNA-34 family in cancer
with particular reference to cancer angiogene-
sis. Exp Mol Pathol 97:298–304. https://doi.
org/10.1016/j.yexmp.2014.08.002
- Maroof H, Salajegheh A, Smith RA, Lam AK
(2014) MicroRNA-34 family, mechanisms of
action in cancer: a review. Curr Cancer Drug
Targets 14:737–751
- Lam A (2015) Chapter 2: Cellular and
molecular biology of esophageal cancer. In:
Saba NF, El-Rayes, Bassel F (eds) Esophageal
cancer: prevention, diagnosis and therapy.
Springer, New York, pp 25–40
- Amin M, Lam AK (2015) Current perspectives
of mi-RNA in esophageal adenocarcinoma:
roles in predicting carcinogenesis, progression
and values in clinical management. Exp Mol
Pathol 98:411–418. https://doi.
org/10.1016/j.yexmp.2015.03.002
- Bobryshev YV, Orekhov AN, Chistiakov DA
(2015) MicroRNAs in esophageal adenocarci-
noma: functional significance and potential for
the development of new molecular disease
markers. Curr Pharm Des 21:3402–3416
- Chen C, Zhang Y, Zhang L, Weakley SM, Yao
Q (2011) MicroRNA-196: critical roles and
clinical applications in development and cancer.
J Cell Mol Med 15:14–23. https://doi.
org/10.1111/j.1582-4934.2010.01219.x
- Matsuzaki J, Suzuki H, Tsugawa H, Watanabe
M, Hossain S, Arai E, Saito Y, Sekine S, Akaike
T, Kanai Y, Mukaisho K, Auwerx J, Hibi T
(2013) Bile acids increase levels of microRNAs
221 and 222, leading to degradation of CDX2
during esophageal carcinogenesis.
Gastroenterology 145:1300–1311. https://
doi.org/10.1053/j.gastro.2013.08.008
- Hemmatzadeh M, Mohammadi H, Karimi M,
Musavishenas MH, Baradaran B (2016)
Differential role of microRNAs in the patho-
genesis and treatment of Esophageal cancer.
Biomed Pharmacother 82:509–519. https://
doi.org/10.1016/j.biopha.2016.05.009
- Derouet MF, Liu G, Darling GE (2014) MiR-
145 expression accelerates esophageal adeno-
carcinoma progression by enhancing cell
invasion and anoikis resistance. PLoS One
9:e115589. https://doi.org/10.1371/jour-
nal.pone.0115589
- Wang Y, Zhao Y, Herbst A, Kalinski T, Qin J,
Wang X, Jiang Z, Benedix F, Franke S,
Wartman T, Camaj P, Halangk W, Kolligs FT,
Jauch KW, Nelson PJ, Bruns CJ (2016) miR-
221 mediates chemoresistance of esophageal
adenocarcinoma by direct targeting of DKK2
expression. Ann Surg 264:804–814. https://
doi.org/10.1097/sla.0000000000001928
- Lynam-Lennon N, Bibby BA, Mongan AM,
Marignol L, Paxton CN, Geiersbach K,
Bronner MP, O'Sullivan J, Reynolds J, Maher
SG (2016) Low miR-187 expression promotes
resistance to chemoradiation therapy in vitro
and correlates with treatment failure in patients
with esophageal adenocarcinoma. Mol Med
22. https://doi.org/10.2119/
molmed.2016.00020
- Sugimura K, Miyata H, Tanaka K, Hamano R,
Takahashi T, Kurokawa Y, Yamasaki M,
Nakajima K, Takiguchi S, Mori M, Doki Y
(2012) Let-7 expression is a significant deter-
minant of response to chemotherapy through
the regulation of IL-6/STAT3 pathway in
esophageal squamous cell carcinoma. Clin
Cancer Res 18:5144–5153. https://doi.
org/10.1158/1078-0432.ccr-12-0701
- Hong L, Han Y, Zhang H, Li M, Gong T, Sun
L, Wu K, Zhao Q, Fan D (2010) The prognos-
tic and chemotherapeutic value of miR-296 in
esophageal squamous cell carcinoma. Ann Surg
251:1056–1063. https://doi.org/10.1097/
SLA.0b013e3181dd4ea9
- Hong L, Han Y, Lu Q, Zhang H, Zhao Q, Wu
K, Fan D (2012) Drug resistance-related
microRNAs in esophageal cancer. Expert Opin
Biol Ther 12:1487–1494. https://doi.org/10
.1517/14712598.2012.711309
- Fassan M, Baffa R, Kiss A, Zaninotto G, Rugge
M (2013) MicroRNA dysregulation in esopha-
geal neoplasia: the biological rationale for
novel therapeutic options. Curr Pharm Des
19:1236–1241
- Garzon R, Marcucci G, Croce CM (2010)
Targeting microRNAs in cancer: rationale,
strategies and challenges. Nat Rev Drug Discov
9:775–789. https://doi.org/10.1038/
nrd3179
- Matsui D, Zaidi AH, Martin SA, Omstead AN,
Kosovec JE, Huleihel L, Saldin LT, DiCarlo C,
Silverman JF, Hoppo T, Finley GG, Badylak
SF, Kelly RJ, Jobe BA (2016) Primary tumor
microRNA signature predicts recurrence and
survival in patients with locally advanced
esophageal adenocarcinoma. Oncotarget
7:81281–81291
- Tang S, Wu WK, Li X, Wong SH, Wong N,
Chan MT, Sung JJ, Yu J (2016) Stratification
of digestive cancers with different pathological
features and survival outcomes by MicroRNA
expression. Sci Rep 6:24466. https://doi.
org/10.1038/srep24466
MicroRNA Detection and Esophageal Adenocarcinoma
